FAIR VALUE OF FINANCIAL INSTRUMENTS
 12 Months Ended
Jun. 30, 2020
Fair Value Disclosures [Abstract]  
FAIR VALUE OF FINANCIAL INSTRUMENTS FAIR VALUE OF FINANCIAL INSTRUMENTS
The following tables summarize the Company’s financial instruments’ adjusted cost, gross unrealized gains and losses, and fair value by significant investment category as of June 30, 2020 and 2019 (in thousands):
June 30, 2020
Adjusted CostGross Unrealized GainsGross Unrealized LossesFair ValueCash and Cash Equivalents (1)Short-Term InvestmentsLong-Term Investments
Level 1
Money market funds$1,055 $— $— $1,055 $1,055 $— $— 
Subtotal$1,055 $— $— $1,055 $1,055 $— $— 
Level 2
Corporate securities1,429 9 — 1,438 — 925 513 
Subtotal$1,429 $9 $— $1,438 $— $925 $513 
Total$2,484 $9 $— $2,493 $1,055 $925 $513 
(1) Cash and cash equivalents on the consolidated balance sheets includes securities that have a maturity of three months or less at the date of purchase. The carrying amount approximates fair value, primarily due to the short maturity of cash equivalent instruments.

June 30, 2019
Adjusted CostGross Unrealized GainsGross Unrealized LossesFair ValueCash and Cash Equivalents (1)Short-Term InvestmentsLong-Term Investments
Level 1
Money market funds$1,328 $— $— $1,328 $1,328 $— $— 
Subtotal$1,328 $— $— $1,328 $1,328 $— $— 
Level 2
Commercial paper$1,123 $— $— $1,123 $524 $599 $— 
Corporate securities83,568 372 (2)83,938 — 57,377 26,561 
U.S agency securities4,702 4 — 4,706 — 3,712 994 
US Government Bonds12,189 20 (1)12,208 — 8,178 4,030 
Subtotal$101,582 $396 $(3)$101,975 $524 $69,866 $31,585 
Total$102,910 $396 $(3)$103,303 $1,852 $69,866 $31,585 
(1) Cash and cash equivalents on the consolidated balance sheets includes securities that have a maturity of three months or less at the date of purchase. The carrying amount approximates fair value, primarily due to the short maturity of cash equivalent instruments.

During fiscal year end June 30, 2020 and 2019, the Company reclassified realized net gain of $371.8 thousand and $30.5 thousand, respectively, to earnings from accumulated other comprehensive income.

During fiscal year end June 30, 2020 and 2019, the Company had $1.0 million and $2.7 million, respectively, of interest income on our investment securities.

The Company had no continuous unrealized loss positions from marketable securities as of June 30, 2020. The following table represents the Company’s marketable securities that had been in continuous unrealized loss position for less than 12 months and for 12 months or greater as of June 30, 2019 (in thousands):
June 30, 2019
Continuous Unrealized Losses
Less than 12 Months12 Months or GreaterTotal
Fair Value of marketable securities$8,072 $— $8,072 
Unrealized Loss$(3)$— $(3)

Based on evaluation of securities that have been in a continuous loss position, we did not recognize any other-than-temporary impairment charges during fiscal year end June 30, 2020 and 2019.

The following table represents the adjusted costs and fair value of cash equivalents and investments by contractual maturity as of June 30, 2020 (in thousands):
Available-For-Sale
Adjusted CostFair Value
Due within 1 year1,978 1,980 
Due after 1 year through 5 years506 513 
Total$2,484 $2,493 

For certain of the Company’s financial instruments, other than those presented in the disclosures above, including cash, accounts receivable, accounts payable and other current liabilities, the carrying amounts approximate fair value due to their short maturities.

As of June 30, 2020 and 2019 the Company had an outstanding loan associated with its credit facilities, which are carried at historical cost. The fair value of the Company’s debt disclosed below was estimated based on the current rates offered to the Company for debt with similar terms and remaining maturities and was a Level 2 measurement. As of June 30, 2020 and 2019, the fair value of the Company’s debt carried at historical cost was $655.0 million and $497.5 million, respectively.